Crossmark

VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1038/s12276-024-01352-6

Published Online: 2024-12-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Su-hyang

Ko, Je Yeong

Jung, Sungju

Oh, Sumin

Kim, Do Yeon

Kang, Eunseo

Kim, Myung Sup

Chun, Kyung-Hee https://orcid.org/0000-0002-9867-7321
Yoo, Kyung Hyun https://orcid.org/0000-0003-2172-5564
Park, Jong Hoon https://orcid.org/0000-0002-8082-0214
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2021R1A6A1A03038890, 2023R1A2C1005868, 2022M3A9B6017654, 2022M3A9B6017654)
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Received: 8 May 2024

Revised: 4 September 2024

Accepted: 6 September 2024

First Online: 2 December 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below